IMAX CORP 10-Q

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds Issuer Purchases of Equity Securities In 2017, the Company’s Board of Directors approved a new $200.0 million share repurchase program for shares of the Company’s common shares that would have expired on June 30, 2020. In June 2020, the Board of Directors approved a 12-month extension of this program which will now expire on June 30, 2021. The repurchases may be made either in the open market or through private transactions, subject to market conditions, applicable legal requirements and other relevant factors. The Company has no obligation to repurchase shares and the share repurchase program may be suspended or discontinued by the Company at any time. During the three months ended September 30, 2020, the Company did not repurchase any shares under this program. As at September 30, 2020, the Company has $89.4 million available under its approved repurchase program. In 2019, IMAX China announced that its shareholders granted its Board of Directors a general mandate authorizing the Board, subject to applicable laws, to repurchase shares of IMAX China in an amount not to exceed 10% of the total number of issued shares of IMAX China as at June 6, 2019 (35,605,560 shares). This program expired on the date of the 2020 Annual General Meeting of IMAX China on June 11, 2020. During the 2020 Annual General Meeting, shareholders approved the repurchase of shares of IMAX China not to exceed 10% of the total number of issued shares as of June 11, 2020 (34,848,398 shares). This program will be valid until the 2021 Annual General Meeting of IMAX China. The repurchases may be made in the open market or through other means permitted by applicable laws. IMAX China has no obligation to repurchase its shares and the share repurchase program may be suspended or discontinued by IMAX China at any time. During the three months ended September 30, 2020, IMAX China did not repurchase any shares under this program. The total number of shares purchased during the nine months ended September 30, 2020, under both the Company and IMAX China’s repurchase plans, does not include any shares purchased in the administration of employee share-based compensation plans. 83 Item 6. Exhibits Exhibit No. Description 10.52 Employment Memorandum, dated September 18, 2020, between IMAX Corporation and Mark Welton. 31.1 Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, dated October 29, 2020, by Richard L. Gelfond. 31.2 Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, dated October 29, 2020, by Patrick McClymont. 32.1 Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, dated October 29, 2020, by Richard L. Gelfond. 32.2 Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, dated October 29, 2020, by Patrick McClymont. 101.INS Inline XBRL Instance Document – The instance document does not appear in the interactive data file because its XBRL tags are embedded within the Inline XBRL document. 101.SCH Inline XBRL Taxonomy Extension Schema Document 101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document 101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document 101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document 101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document 104 Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101) 84 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. IMAX CORPORATION Date: October 29, 2020 By: /s/ PATRICK MCCLYMONT Patrick McClymont Executive Vice-President & Chief Financial Officer (Principal Financial Officer) Date: October 29, 2020 By: /s/ KEVIN M. DELANEY Kevin M. Delaney Senior Vice-President, Finance & Controller (Principal Accounting Officer) 85